Publication: 2258

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.
      Google Scholar   
Citation:
J Thorac Oncol vol 11 (6) 850-61
Year:
2016
Type:
Manuscript
Funding:
Not Funded
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
http://www.ncbi.nlm.nih.gov/pubmed/26899019
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
5
Parents:
850   853   2173  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821  
Corr. Author:
 
Authors:
                                 
Networks:
11030, LAPS-MA036, NY141   
Study
CALGB-150802
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-9633
Phases:
N/A, 3
Keywords:
Lung cancer, Predictive, Prognostic, TP53 mutations